B. Braun Medical Inc. is recalling over 7.3 million Hemodialysis Bloodlines, including StreamLine and Low Volume models, due to the potential for small air bubbles to accumulate in the arterial lines during use. This issue occurs because blood gases can adhere to the tubing under negative pressure. The recall affects millions of units manufactured throughout mid-2025 and distributed to medical facilities across the United States and Canada.
Air bubbles in the bloodline can lead to an air embolism, a life-threatening condition where air enters the patient's bloodstream and blocks blood flow to vital organs. While no injuries have been reported, the defect poses a critical risk during dialysis treatments.
Recall Number: Z-1798-2026; Distributed quantity: 3,158,104 units
Recall Number: Z-1799-2026; Distributed quantity: 2,653,711 units
Recall Number: Z-1800-2026; Distributed quantity: 1,174,271 units
Recall Number: Z-1801-2026; Distributed quantity: 328,640 units
Recall Number: Z-1802-2026; Distributed quantity: 4,848 units
Recall Number: Z-1803-2026; Distributed quantity: 4,884 units
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.